Lidoposterin

Lidocaine, the active ingredient in Lidoposterin, is a local anesthetic presented as a topical preparation for cutaneous and rectal use. It provides temporary numbness and pain relief for minor skin procedures and superficial irritations in adult patients.

GNH USA supplies Lidoposterin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable batch‑to‑batch consistency for global procurement. Our distribution network ensures timely delivery across Europe, Asia and the Americas.

Lidoposterin, a lidocaine‑based local anesthetic, is used to provide analgesia in superficial tissue procedures.

- Minor skin procedures: provides rapid surface anesthesia to facilitate incision or removal of lesions. - Superficial wound pain: reduces discomfort from cuts, abrasions, or burns. - Irritation relief: alleviates pain associated with minor dermatologic irritations.

Topical lidocaine can be associated with a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Localized burning or stinging at the application site. - Redness or mild erythema. - Pruritus or itching. - Swelling or edema of the treated area.

Serious or Rare Side Effects: - Allergic contact dermatitis with vesiculation. - Systemic toxicity manifesting as dizziness, tinnitus, or visual disturbances. - Cardiac arrhythmias in cases of excessive absorption. - Seizures secondary to high plasma concentrations.

When using Lidoposterin, consider the following safety measures.

- Patient assessment: verify no known hypersensitivity to amide‑type local anesthetics before use. - Application area: avoid use on broken skin, mucous membranes, or large surface areas to limit systemic absorption. - Concomitant agents: do not combine with other topical anesthetics containing lidocaine or similar agents without professional guidance. - Medical conditions: exercise caution in patients with cardiac conduction disorders or severe hepatic impairment. - Pediatric use: limit exposure in children; dosing and area should be determined by a qualified clinician. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Lidoposterin may interact with other medicines; awareness of the level of interaction helps manage risk.

Major Interactions (Avoid): - Concurrent use with Class I antiarrhythmic drugs (e.g., quinidine, procainamide) may potentiate cardiotoxic effects. - Co‑administration with other potent sodium‑channel blockers (e.g., bupivacaine) can increase risk of systemic toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole) may reduce lidocaine metabolism, raising plasma levels. - Beta‑blockers may enhance lidocaine’s cardiac effects, requiring ECG monitoring. - High‑dose epinephrine may alter lidocaine absorption, affecting duration of action.